ResearcherShanxi Medical UniversityActive in the last 2 years

Zhigang Wei

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5124321863. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

Unraveling the roles of DKK1 and S100P in pancreatic ductal adenocarcinoma: Insights from machine learning, single-cell/spatial transcriptomics, and functional… Last author DOI 10.1016/j.tranon.2026.102949 ↗
KRT13 Drives Pancreatic Cancer Malignancy Via the PI3K/AKT-PPARG Axis While Enhancing Sensitivity to Navitoclax. Co-author DOI 10.12659/msm.952797 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yanzhao Mao · 1 shared paper, 2026 · strength 0.30
- Paper Unraveling the roles of DKK1 and S100P in pancreatic ductal adenocarcinoma: Insights from machine learning, single-cell… DOI 10.1016/j.tranon.2026.102949 ↗
Yongping Cui · 1 shared paper, 2026 · strength 0.30
- Paper KRT13 Drives Pancreatic Cancer Malignancy Via the PI3K/AKT-PPARG Axis While Enhancing Sensitivity to Navitoclax. DOI 10.12659/msm.952797 ↗
Chaojie Liang · 1 shared paper, 2026 · strength 0.30
- Paper KRT13 Drives Pancreatic Cancer Malignancy Via the PI3K/AKT-PPARG Axis While Enhancing Sensitivity to Navitoclax. DOI 10.12659/msm.952797 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.